Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma
Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma
Active, not recruiting · NCT06079164 · Registry updated 2026-08-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Active, not recruiting | Phase 1 | 2026-08-25 | NCT06079164 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kite, A Gilead Company | 27 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cross Cancer Institute | Edmonton | Canada | 11 |
| Henry-Joyce Cancer Clinic | Nashville | United States | 16 |
| Jewish General Hospital | Montreal | Canada | 15 |
| QEII Health Sciences Centre | Halifax | Canada | 2 |
| Royal Brisbane and Women's Hospital | South Brisbane | Australia | 2 |
| Royal Prince Alfred Hospital | Camperdown | Australia | 83 |
| St. David's South Austin Medical Center | Austin | United States | 11 |
| Swedish Cancer Institute | Seattle | United States | 67 |
| Sylvester Comprehensive Cancer Center | Miami | United States | 37 |
| The Alfred Hospital | Melbourne | Australia | 110 |
| University of Chicago Medical Center | Chicago | United States | 152 |